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Motor neuronAmyotrophic lateral sclerosis (ALS) is characterised by substantial loss of both upper and lower motor neuron
function, with sensory and cognitive systems less affected. Though heritable forms of the disease have been
described, the vast majority of cases are sporadic with poorly deﬁned underlying pathogenic mechanisms.
Here we demonstrate that the neurological pathology induced in transgenic mice by overexpression of
γ-synuclein, a protein not previously associated with ALS, recapitulates key features of the disease, namely
selective damage and loss of discrete populations of upper and lower motor neurons and their axons, contra-
sted by limited effects upon the sensory system.
© 2012 Elsevier Inc. Open access under CC BY license.Introduction
Amyotrophic lateral sclerosis (ALS) is characterised by the severe
deﬁciency of both upper and lower motor neuron function, with senso-
ry and cognitive systems less affected. Though ALS-associated genetic
alterations have been identiﬁed in several loci (DeJesus-Hernandez et
al., 2011; Deng et al., 2011; Kwiatkowski et al., 2009; Maruyama et al.,
2010; Renton et al., 2011; Rosen et al., 1993; Sreedharan et al., 2008;
Vance et al., 2009) the vast majority of clinical cases are sporadic, with
scant evidence of common risk factors (Chio et al., 2009; van Es et al.,
2009; Wain et al., 2009). In order to fully understand and ultimately
treat ALS it is essential we broaden our spectrum of knowledge beyond
the disease's genetic background, and consider novel factors that might
contribute to its underlying pathology. γ-Synuclein, a cytosolic protein
abundant in the perikarya, presynaptic terminals and particularly with-
in the axons of select populations of CNS and PNS neurons (Buchman et
al., 1998), is a close relative ofα-synuclein— a protein robustly linked to, Dorsal root ganglion; TDP-43,
a/translocated in liposarcoma;
horylated neuroﬁlament.
.
irect.com).
 license.the idiopathic (Edwards et al., 2010; Pankratz et al., 2009; Satake et al.,
2009; Simon-Sanchez et al., 2009) and familial (Chartier-Harlin et al.,
2004; Ibanez et al., 2004; Kruger et al., 1998; Polymeropoulos et al.,
1997; Singleton et al., 2004; Zarranz et al., 2004) forms of neurodegen-
erative diseases known as synucleinopathies. Intracellular accumula-
tion, oligomerisation and aggregation of α-synuclein are arguably
causes of pathology, with the presence of inclusions formed from ﬁbril-
lated α-synuclein being a hallmark of these diseases. γ-Synuclein
shares this ability to aggregate (Park and Lansbury, 2003) and, though
not identiﬁed as a constituent of any common lesions such as Lewybod-
ies, has been described as a component of atypical inclusion bodies in
human neurodegenerative conditions (Galvin et al., 1999, 2000;
Surgucheva et al., 2002) and rodent axonopathy models (Nguyen et
al., 2011; Wang et al., 2004). Changes in γ-synuclein expression and
its pathological accumulation in speciﬁc regions of the optic nerve
(Buckingham et al., 2008; Nguyen et al., 2011; Soto et al., 2008;
Surgucheva et al., 2002) are emerging as possible contributing factors
in glaucoma. Polymorphisms in the γ-synuclein locus have recently
been associated with human diffuse Lewy body disease (Nishioka et
al., 2010). Taken together with high abundance of γ-synuclein in
motor neurons and particularly their axons (Buchman et al., 1998;
Ninkina et al., 2003, 2009), these observations raised a possibility that
dysfunction of this protein might be directly involved in the pathogen-
esis of some forms ofmotor neuron diseases. This prompted us to inves-
tigate if certain characteristic features of ALS pathology were
recapitulated in the mouse model of γ-synucleinopathy.
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Experimental animals
The generation of Thy1mγSN mice on a pure C57Bl6J genetic back-
ground has been described previously (Ninkina et al., 2009). All animal
works were carried out in accordance with the United Kingdom Ani-
mals (Scientiﬁc Procedures) Act (1986).
Inverted grid test
To assess limbmuscle strength a mouse was placed onto a 30 cm by
30 cm square mesh consisting of 5 mm squares of 0.5 mm diameter
wire. The grid was slowly rotated to inverted position and held 30 cm
above the surface of a thick layer of bedding material. If a mouse fell
from the inverted grid earlier than the maximum test time of 1 min
the latency to fall was noted and after an appropriate rest in the home
cage the test was repeated. The best time from three attempts was in-
cluded in the statistics. At minimum 9 mice were tested in each group.
Analysis of hind paw withdrawal threshold following tactile stimulation
Mice were placed in a plastic cage with a mesh base composed of
5 mm squares of 0.5 mm diameter wire and allowed 30minutes to ha-
bituate. Tests were only carried out when the animal was still, with all
four paws on the cage surface. Von Frey hairs (SOMEDIC, Sweden) of
varying force (0.12 g–6.20 g) were applied from beneath the animal
to the plantar surface, taking care to avoid the footpads, for approxi-
mately 2 seconds. Each hair was applied ten times. Increasing force of
von Frey hair was used until either the highest force hair or the 100%
withdrawal threshold was met. Responses considered valid were the
lifting of paws from surface of the grid or the spanning of digits upon
stimulation. The latter response was frequently observed when the
lowest force hairs were used. A minimum of 7 animals were tested in
each group.
Sequential protein fractionation
Protein from cytosolic fractions of motor and sensory cortices of
12-month old mice were fractionated as described previously
(Ninkina et al., 2009).
Quantitative Western blotting
Previously described protocols were used for Western blotting
(Buchman et al., 2002). Protein levels were quantiﬁed using Cy3- or
Cy5-conjugated secondary antibodies (Invitrogen, CA) and FluorChem
Q MultiImage III system (Cell Biosciences, CA).
Histological techniques
For Nissl staining sections were incubated in 0.5% cresyl fast violet
solution (Sigma-Aldrich, MO) and differentiated in acidiﬁed ethanol.
Nissl stained cranial motor neuron cell bodies and DRG sensory cell
bodies were identiﬁed by their large cell body densely stained with
Nissl granules, clear nuclear envelope and intensely stained nucleo-
lus. Every 10th section of the abducens, facial and trigeminal motor
nucleus, and 6th section of L4/5 DRG was sampled. The total number
of cells for each population was estimated using the cell fractionator
technique. Immunostaining was carried out as described previously
(Ninkina et al., 2003, 2009) using Elite plus kits (Vector Laboratories,
CA) and 3,30-diaminobenzidine as a substrate (Sigma-Aldrich, MO)
or Alexa Fluor-conjugated secondary antibodies (Invitrogen, CA). Ex-
pression of RNA and proteins in the mouse retina whole mounts was
carried out as described previously (Nguyen et al., 2011; Surgucheva
et al., 2002).Primary antibodies
Antibodies against γ-synuclein (rabbit polyclonal SK23, afﬁnity pu-
riﬁed), NF-L (mouse monoclonal, clone DA2, Cell Signaling, MA),
NF-M (mouse monoclonal, clone NN18, Sigma, MO), NF-H (rabbit poly-
clonal, Sigma,MO),α-tubulin (mousemonoclonal, cloneDM1A, Sigma,
MO), peripherin (rabbit polyclonal, Chemicon, MA), myelin basic pro-
tein (mouse monoclonal, clone MAB387, Chemicon, MA), GFAP (rabbit
polyclonal, Sigma-Aldrich, MO) and NeuN (mouse monoclonal,
Chemicon, MA) were used as described previously (Ninkina et al.,
2009). Biotinylated lectin ricin communis agglutinin 1 was used for de-
tection of microglia as suggested by the manufacturer (Vector). For ret-
ina studies, antibodies against γ-synuclein (rabbit polyclonal to
C-terminal 16 amino acids, afﬁnity puriﬁed) and pNF (SMI31, Covance,
NJ) were used as described previously (Nguyen et al., 2011). In situ
hybridisation to γ-synuclein mRNAwas carried as described previously
(Soto et al., 2008).
Transmission electron microscopy
Nerves were submerged in cold 2% paraformaldehyde, 2%
gluteraldehyde in 0.1 M Sorenson's PB, post-ﬁxation in 1% osmium
tetraoxide, block stained in 0.5% uranyl acetate and embedded in ara-
ldite (Agar Scientiﬁc, UK). Semi-thin section (0.6 μm) were collected
and stained with 1% toluidine blue, 1% borax in dH2O. Ultra-thin sec-
tions (0.095 μm) were mounted on a 0.8% pioloform ﬁlm coated cop-
per slot grids (Agar Scientiﬁc, UK) and counterstained with 2% uranyl
acetate and Reynold's lead citrate. Axon area measurements were
made using ImageJ analysis software (NIH, MD).
Morphometric analysis of sciatic nerve and spinal nerve roots
Myelinated A-ﬁbres and unmyelinated C-ﬁbre were countedwithin a
randomly selected ﬁeld at 2000×magniﬁcation. All A-ﬁbres were count-
ed recording their morphological condition, with ﬁbres classed as either
normal or damaged. Healthy ﬁbres were deﬁned as those with both
axons and myelin sheath intact. Unhealthy ﬁbres had dense, vacuous or
absent axons, substantial abnormalities in themyelin sheath, or a combi-
nation of both. Damaged axons fully enveloped by phagocytes were not
counted as the digestive process of these cells made accurate quantiﬁca-
tion impossible. All counts were normalised to a 100 μm2. Axon area
measurements were made using ImageJ analysis software (NIH, MD).
Results
Motor neuron populations are selectively vulnerable to the overexpression
of γ-synuclein
We have previously demonstrated that mice with Thy1 promoter
driven-overexpression of murine γ-synuclein in many central and pe-
ripheral neuron populations (herein Thy1mγSN mice) develop a pro-
gressive, age-dependent motor dysfunction, correlating with the
formation of γ-synuclein-containing inclusion bodies, which are nega-
tive for TDP-43, FUS, α-synuclein, tau and only occasionally
ubiquitin-positive, and substantial depletion of motor neuron pools at
all levels of the spinal cord (Ninkina et al., 2009). In addition to severe
loss of spinal motor neurons, a typical feature of ALS is the loss of
lower motor neuron in selective brainstem populations (Wijesekera
and Leigh, 2009). Therefore we stereologically counted neurons in cra-
nial motor nuclei of severely affected 12-month old Thy1mγSN and
age-matched healthy wild type mice. Signiﬁcant neuron loss, compara-
ble with that seen in the spinal cord was observed in the trigeminal
motor nucleus (33.9% loss, p=0.0012, Mann–Whitney U-test), whilst
a normal complement of motor neurons was found in the facial and
abducens nuclei of transgenic mice (Fig. 1a, A.1a–g and Table A.1). Con-
sistently, astrogliosis and microgliosis, which are commonly associated
Fig. 1. Cranial motor regions of γ-synuclein transgenic mice show a selective pattern of damage. Quantiﬁcation of motor neurons (mean±SEM, **pb0.005) in facial (ai) and trigeminal
motor (aii) nuclei of 12-month old wild type and Thy1mγSN mice. The number of nuclei assessed is shown. Levels of transgene expression in the motor trigeminal and facial nuclei of
presymptomatic 4-month old Thy1mγSN mice measured by quantitative real-time RT-PCR, using RNA extracted from fresh tissue microdissected from 1 mm brain slices of individual
animals (aiii). The number of animals from which cranial nuclei were dissected bilaterally is shown. Immunoﬂuorescent staining of the wild type (bi, biii) and Thy1mγSN (bii, biv)
mouse brain sections with antibodies against NeuN (green) and GFAP (red) shows substantially higher level of astrogliosis in the trigeminal motor nucleus (biv) than in facial nucleus
(bii) of transgenic mice. Ricin communis agglutinin 1 (RCA) lectin labeling (c) revealed a similar trend for microgliosis, with a considerably higher level in the trigeminal motor nucleus
(cii) than facial nucleus (ci). Various abnormal γ-synuclein-positive structures (di insert, arrow=axonal spheroid, arrowhead=perikaryal cytoplasmic inclusion) were distinctly more
abundant in the Thy1mγSNmotor cortex (di) than the somatosensory cortex (dii), as were activated astrocytes (ei, eiii) andmicroglial cells (eii, eiv). Scale bars: b, c=50 μm, d, e=25 μm.
126 O.M. Peters et al. / Neurobiology of Disease 48 (2012) 124–131with neurodegeneration, were most prominent in the affected nucleus
(Fig. 1b, c). Notably, the selective nature of γ-synuclein induced pathol-
ogy did not coincide with substantial differences in transgene expres-
sion between nuclei, with Thy1mγSN transgene expression found to
be slightly higher in the resistant facial nucleus than in the sensitive
motor trigeminal nucleus (Fig. 1aiii, A.1h–k). Evidence of selective neu-
ronal dystrophy was also observed in the cortex, with perikaryal andaxonal accumulation of γ-synuclein (Figs. 1d, A. 2a), accumulation of
detergent-insoluble species (Fig. A. 2b), and substantial gliosis observed
withinmotor regions (Figs. 1e, A. 2c, d), however all to a lesser degree in
the somatosensory regions. These results suggest thatγ-synuclein over-
expression is damaging to select lower and upper motor neuron
populations, a hallmark feature of human ALS (Wijesekera and Leigh,
2009) also detected in some rodentmodels of ALS (Ferrucci et al., 2010).
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Thy1mγSN mice correlate with the development of motor deﬁcits
ALS-associated motor neuron cell body loss is generally accompa-
nied by the degeneration of their processes. Quantitative Western
blotting revealed changes in the levels of several major axonal cyto-
skeletal proteins in the sciatic nerve of Thy1mγSN mice with severe
motor phenotype. Levels of all three neuroﬁlament proteins and
α-tubulin were substantially reduced compared to the nerves of
age-matched wild type mice, whereas peripherin and actin levels
remained unchanged (Fig. 2h and Table A. 2). Levels of the 18 kDa
and 21 kDa isoforms of myelin basic protein, principal components
of the axonal myelin sheet, were also reduced.
Substantial reductions in the levels of cytoskeletal and myelin
markers suggested a gross change in sciatic nerve morphology. In-
deed, a sparser distribution and deterioration of myelinated axons
was clearly evident in severely affected Thy1mγSN mice (Fig. 2b). A
substantial number of the myelinated ﬁbres were noted to have a
highly abnormal morphology, including damage to their myelin
sheath (Fig. 2c–e). Widespread invasion by phagocytes containingFig. 2. Severe damage of ﬁbres in the sciatic nerves of mice overexpressing γ-synuclein. Elec
Abnormal myelinated ﬁbres are abundant in Thy1mγSN (b) but not wild type mice (a). Rep
or a highly degraded multilamellar structure (e) are shown. Quantiﬁcation of total, healthy a
and Thy1mγSN mice (mean±SEM, ***pb0.001, Mann–Whitney U-test). Representative Wes
nerves of 12-month old Thy1mγSN mice. For full quantiﬁcation see Table A. 2. Scale bar: a,whirls of digested myelin (Fig. 2b) indicated active Wallerian-like de-
generation of the nerve. Quantitative analysis revealed a signiﬁcant
reduction in the total number of the myelinated ﬁbres in the sciatic
nerve of Thy1mγSN mice (24.9% less ﬁbres than in wild type mice,
p=0.0005, Mann–Whitney U-test) and, when classiﬁed by morpho-
logical condition, a prominent loss of healthy ﬁbres (38.6%,
pb0.0001, Mann–Whitney U-test) was accompanied by a dramatic
~8 times increase in damaged ﬁbres (Fig. 2f). No loss of unmyelinated
sensory C-ﬁbres was observed in the sciatic nerve of symptomatic
Thy1mγSN mice (Fig. 2g). The presence of structural changes in the
sciatic nerve of Thy1mγSN mice correlated with the severity of
motor phenotype. Only a minor reduction in the levels of structural
proteins, slight alteration of the morphology and no loss of ﬁbres
were observed in transgenic mice with a mild deﬁcit of motor func-
tion (Tables A. 2 and A. 3).
No progressive loss of tactile sensory perception in Thy1mγSN mice
Motor dysfunction is widely accepted as the main clinical feature
of ALS, while functional and morphological changes in the sensorytron micrographs of transverse sections of the sciatic nerve of 12-month old mice (a–e).
resentative images of ﬁbres with damage to their myelin sheath (c), damaged axon (d)
nd damaged myelinated ﬁbres (f) and total C-ﬁbres (g) in the sciatic nerve of wild type
tern blot (h) shows that levels of several structural proteins are decreased in the sciatic
b=3 μm.
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and typically modest (Guo et al., 2009; Hammad et al., 2007; Isaacs et
al., 2007; Kawamura et al., 1981; Pugdahl et al., 2007). Myelinated ﬁ-
bres in the sciatic nerve include both afferent and efferent neuron
projections, and therefore it was important to investigate if the dam-
age observed in Thy1mγSN mice had a debilitating effect on both the
motor and sensory system. In contrast to the age-correlated decline of
motor function in Thy1mγSNmice, previously revealed in the rotarod
tests (Ninkina et al., 2009) and here illustrated by results of the
inverted grid test (Fig. 3b), assessment of hind-paw withdrawal
threshold following tactile stimulation of the plantar surface revealed
no progressive deﬁcit between the evoked response of 6-week,
4-month and 8-month old animals (Fig. 3a). Histological assessments
of ganglia also demonstrated sensory system preservation—neither
γ-synuclein inclusions nor gliosis (Fig. A. 3) was observed and stereo-
logical counting revealed no loss of sensory neurons in the L4/5 dorsal
root ganglia in 12-month old Thy1mγSN mice (Fig. 3c), despite the
high level of transgene expression in these ganglia (Ninkina et al.,
2009).
Myelinated ﬁbres are more affected in ventral than dorsal roots of the
spinal nerves of 12-month old Thy1mγSN mice
To further investigate the pattern of myelinated ﬁbre degeneration
induced by γ-synuclein overexpression, we assessed the morphology
of the discrete pools of sensory and motor ﬁbres located in lumbarFig. 3. The progressive motor deﬁcit seen in Thy1mγSN mice is not accompanied by
changes in tactile sensitivity. Inverted grid test and response to tactile stimulation of
the hind plantar surface (mean±SEM, *pb0.05, ***pb0.001 Mann–Whitney U-test).
Thy1mγSN mice develop no impairment in response to tactile stimuli between
6 weeks, 4 months and 8 months (a). In contrast the ability of Thy1mγSN mice to
hang from an inverted grid substantially diminished with age (b). Inset number de-
notes percentage of animals able to successfully complete the 60-second test. The
number of neurons in L4/5 dorsal root ganglia (mean±SEM) of severely affected
12-month old Thy1mγSN mice and healthy age-matched wild type controls (c).dorsal and ventral nerve roots respectively. The orderly distribution of
myelinated motor ﬁbres seen in ventral roots of wild type mice
(Fig. 4a)was substantially disrupted in Thy1mγSNmice (Fig. 4b). Quan-
tiﬁcation revealed a signiﬁcant loss of myelinatedmotor ﬁbres and high
proportion of severely damaged ﬁbres (Fig. 4c, Table A. 4). Similar to
changes found in the sciatic nerve, we observed an 18% decrease in
numbers of total ﬁbres, 33.9% decrease in healthy ﬁbres and 10.8
times increase in numbers of damaged ﬁbres contained in the ventral
roots of Thy1mγSN mice compared to the corresponding values of
wild type mice (pb0.001 for all, Mann–Whitney U-test). These patho-
logical changes were accompanied by extensive phagocyte inﬁltration
(Fig. A. 4). It has been demonstrated that in the peripheral nerves of
ALS patients (Kawamura et al., 1981) and rodent models of the disease
(Bruijn et al., 1998; Kong andXu, 1998; Shan et al., 2010) the largest cal-
iber myelinated motor ﬁbres degenerate more readily than the smaller
class of slow-ﬁring ﬁbres. Analysis of the size and size distribution of
remaining myelinated motor ﬁbres in the ventral roots of Thy1mγSN
mice showed a substantial 49.5% decrease (pb0.001, Mann–Whitney
U-test) in the mean myelinated ﬁbre size compared to wild type mice,
caused by a disproportionate loss of the largest caliber ﬁbres (Fig. 4g).
In contrast, the vast majority of ﬁbres in the dorsal roots of Thy1mγSN
micewere healthy and equal in number (Fig. 4f and Table A. 4), size and
size distribution (Fig. 4h) to those of wild type animals, though some
abnormal myelinated ﬁbres (Fig. 4f) and phagocytes (Fig. A. 4b) were
observed.
Further evidence of selective sensitivity of various neuronal
populations to γ-synuclein overexpression came from studies of the
retina of 12-month old Thy1mγSN mice. Despite high levels of trans-
genic RNA and protein expression in the retinal ganglion cells, RGCs
(Fig. 5a), no evidence of cell bodies or axon degeneration was
detected. There was no obvious increase in the number of RGCs
with somatic accumulation of phosphorylated neuroﬁlament
(Fig. 5a), a marker of damaged RGCs (Buckingham et al., 2008;
Nguyen et al., 2011). Quantiﬁcation of sensory axons in ultra-thin sec-
tions of optic nerve revealed no loss (Fig. 5d, Table A. 5), and no
changes in axon size (Fig. 5e) or myelin sheath thickness (denoted
by g-ratio) were detected (Fig. 5f). Taken together these results sug-
gest preservation of this sensory system in Thy1mγSN mice.Discussion
The pattern of neurodegeneration developed in the nervous sys-
tem of Thy1mγSN mice recapitulates several notable pathological
features common to sporadic and familial forms of ALS. These include
a progressive decline in motor function caused by severe damage to
motor ﬁbres, in particular those of largest caliber, in peripheral nerves
and substantial loss of selective motor neuron populations; preserva-
tion of sensory neurons morphology and function, including those of
the visual system; prominent neuroinﬂammation restricted to areas
where signiﬁcant damage of motor neurons is evident. The absence
of TDP-43 or FUS pathology in Thy1mγSN mice indicates that the de-
velopment of γ-synuclein pathology is most likely a downstream
event in pathogenesis of diseases triggered by dysfunction of the for-
mer proteins. Although γ-synuclein is not currently recognised as a
major contributing factor in human neurodegenerative diseases,
there is a growing body of evidence that under certain conditions
this protein plays a role in axonal dysfunction in both humans
(Galvin et al., 1999, 2000), and mice (Nguyen et al., 2011; Ninkina
et al., 2009; Soto et al., 2008; Wang et al., 2004). Our data now sug-
gests that disruption of normal γ-synuclein metabolism, followed
by its aggregation, might be a contributing factor in the pathogenesis
of ALS, a hypothesis supported by our recent ﬁnding (unpublished
observations, manuscript submitted) that revealed accumulation
and aggregation of γ-synuclein in a subset of ALS cases. The Thy1-
mγSN mouse line may thus provide a useful tool in dissecting the
Fig. 4. The population of motor ﬁbres entering the sciatic nerve are both damaged and diminished. Representative toluidine blue stained transverse semi-thin sections through ven-
tral (a, b) and dorsal (d, e) nerve roots of 12-month old wild type (a, d) and Thy1mγSN (b, e) mice. Quantiﬁcation of total, healthy and damaged myelinated ﬁbres in L4–L5 ventral
(c) and dorsal (f) nerve roots of 12-month old mice (mean±SEM, ***pb0.001 Mann–Whitney U-test). The size (mean area±SEM, ***pb0.001, Mann–Whitney U-test) and size
distribution of motor nerve ﬁbres is signiﬁcantly smaller in the ventral nerve root of 12-month old severely affected Thy1mγSN than age-matched wild type mice (gi), due to a
distinct shift towards smaller classes of ﬁbre surviving (gii). The mean area and size distribution of sensory ﬁbres do not differ between genotypes (hi, hii). The number of animals
analysed and total number of ﬁbres measured (in brackets) are shown. Scale bars: a–d=50 μm.
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Fig. 5. Retinal ganglion cells and their axons in the optic nerves do not degenerate after overexpression of γ-synuclein in Thy1mγSN mice. Detection of γ-synuclein mRNA expres-
sion by in situ hybridisation (red), protein expression by immunostaining with antibodies against γ-synuclein (green) and damaged RGCs by immunostaining with antibody against
phosphorylated neuroﬁlaments (blue) in whole mounted retina of 12-month-old Thy1mγSN and wild type mice (a). Representative electron micrographs of transverse sections of
the optic nerve of 12-month old wild type (b) and Thy1mγSN mice (c), and quantiﬁcation of total number of myelinated ﬁbres (d), mean ﬁbres area (e) or g-ratio (f) of ﬁbres
(mean±SEM, Mann–Whitney U-test). The total number of ﬁbres measured and animals analysed (in brackets) are shown. Scale bars: a=500 μm, b, c=1 μm.
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